As mentioned in Announcement no. 02/2020 Coloplast initiated a share buyback programme totalling up to DKK 500 million.

The programme commenced on 24 February 2020 and expected to end by 24 August 2020.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed on 24 August 2020:

DateNumber of sharesAverage purchase price, DKKTransaction value, DKK
24 August 20201,7971049.991,886,832
Accumulated until now under the programme504,899990.30499,999,857

Henceforth, Coloplast owns 3,322,745 treasury B shares of DKK 1 equal to 1.54% of the company’s total share capital.

An overview showing the transaction data for 24 August 2020 is enclosed.

Coloplast's share buyback programme, initiated on 24 February 2020, and as described in Announcement no. 02/2020, is hereby completed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800


For further information, please contact
Investors and analysts
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 / +45 4911 3376

Rasmus Sørensen
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 1786
Press and the media
Lina Danstrup
Sr. Media Relations Manager
Tel. +45 4911 2607

Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Company reg. (CVR) no. 69749917


This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-08.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.